上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1330Please respect copyright.PENANAppBSsZnik6
1330Please respect copyright.PENANAkjkV5PR5Zp
上集:https://www.penana.com/article/4711251330Please respect copyright.PENANAPKotwue246
1330Please respect copyright.PENANAVjHVymG22v1330Please respect copyright.PENANAQ5gKyOODf3
1330Please respect copyright.PENANAsS0OyENDl0
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1330Please respect copyright.PENANAEQZiQohipQ
1330Please respect copyright.PENANAnlyp0D1gKk
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1330Please respect copyright.PENANANCxM9ndsAH
1330Please respect copyright.PENANAAtJ9k4Stpl
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1330Please respect copyright.PENANASzS7tB6ZX3
1330Please respect copyright.PENANAHTtn1WqxCK1330Please respect copyright.PENANA9gHBSVv3RR
1330Please respect copyright.PENANA905LcCbEsP
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1330Please respect copyright.PENANAuHvauQK62p
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1330Please respect copyright.PENANAcAldlR8ctp
1330Please respect copyright.PENANAD0GWUeVHx6
忘記甚麼是Neoantigen的話,可重溫上一集。1330Please respect copyright.PENANA16wUkiVEbQ
1330Please respect copyright.PENANA49jhseGFjJ
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1330Please respect copyright.PENANAUfatMltSMD
1330Please respect copyright.PENANAqm6CsU57Ks
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1330Please respect copyright.PENANALZtKjYFDUe
1330Please respect copyright.PENANAOo0I3wP60o1330Please respect copyright.PENANAjzE0mAQnYR
1330Please respect copyright.PENANAWtSCSPOrob
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1330Please respect copyright.PENANARraReYmdPN
1330Please respect copyright.PENANAUTre6euQMp
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1330Please respect copyright.PENANA0PJ7UJaYCF
1330Please respect copyright.PENANAQy0DxTvdFz
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1330Please respect copyright.PENANAsG62BciGDE1330Please respect copyright.PENANADd7MPCAjM3
1330Please respect copyright.PENANAed6zBnSPOB
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1330Please respect copyright.PENANAQmoyfqBVTk
1330Please respect copyright.PENANAfT8JXn4WCA
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1330Please respect copyright.PENANAfUSfELDkPX1330Please respect copyright.PENANAT05DYVOsiY
1330Please respect copyright.PENANARw06tihSQp
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1330Please respect copyright.PENANAzUmAkrE49i
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1330Please respect copyright.PENANA7pTQZewC4f
1330Please respect copyright.PENANAks2R7cEicz
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1330Please respect copyright.PENANA34NIXSDVDC
1330Please respect copyright.PENANAL451lMS05l
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1330Please respect copyright.PENANADNrhQxDA35
1330Please respect copyright.PENANA42vqXLVzlV
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1330Please respect copyright.PENANAiPcYJf4y9n
1330Please respect copyright.PENANAI7kIhdXl8U
1330Please respect copyright.PENANA3713fLiuVS
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1330Please respect copyright.PENANA7B7SUyKmgh
1330Please respect copyright.PENANAqCMAeZ4Enj
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1330Please respect copyright.PENANAXIogT8VJPx
1330Please respect copyright.PENANABKldoFrQLG
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1330Please respect copyright.PENANA4nyIR7PkTF
1330Please respect copyright.PENANAitd7TQzaHR
Link:1330Please respect copyright.PENANARx1S9CXTDd
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1330Please respect copyright.PENANAYiziePBSXQ
1330Please respect copyright.PENANAmwEIqEAjgp
1330Please respect copyright.PENANAmvovBgPDeA
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1330Please respect copyright.PENANAidACNqz03I